Marvell's $115 billion Lumentum deal is already worth about 27% less per share

Marvell Technology said Monday it will acquire optical-components maker Lumentum in an all-stock deal that the companies put at an implied enterprise value of $115 billion. The figure is real, but it is a snapshot from before the stocks fell. Because no cash changes hands, what Lumentum holders actually get is whatever 4.5 Marvell shares are worth, and that number moves every second.

The terms, from the companies' release

According to the joint press release, Lumentum stockholders receive a fixed 4.500 Marvell shares for each Lumentum share. The companies say that works out to about $1,132 per Lumentum share, a premium of roughly 23.9% to each company's unaffected close on October 28, the last trading day before deal speculation began. Marvell holders would own about 67% of the combined company and Lumentum holders about 33%.

Matt Murphy stays chairman and CEO. Three Lumentum directors, including CEO Michael Hurlston, join Marvell's seven-member board. Closing is expected in the first half of calendar 2028 and needs both companies' stockholders and regulators to approve. Marvell says it sees more than $1 billion in annual run-rate cost synergies and expects the deal to add to its non-GAAP earnings per share in the first year after closing. CNBC, which also reported the deal, notes the structure means the headline value rises and falls with Marvell stock.

The number behind the number

A fixed exchange ratio makes the arithmetic simple. We read both stocks on Nasdaq.com at 9:51 AM ET Monday:

Working backward from the release, $1,132 divided by 4.5 implies Marvell closed near $251.60 on October 28, so Marvell stock has dropped about 27% since then, taking the offer with it. The same release implies an unaffected Lumentum price near $914 (1,132 divided by 1.239), which puts Lumentum about 18% below where it traded before the deal talk began. These are our calculations from the companies' stated figures, not numbers either company published. Other outlets lead with a smaller number: the Wall Street Journal's headline puts the deal at $80 billion, which is consistent with valuing it at recent prices rather than October 28 prices.

The roughly 9% gap between Lumentum's price and the value of the offer is the market's way of saying the deal is more than two years from closing, needs approvals, and that Marvell's own stock could keep moving. The gap is not a forecast that the deal fails. It is the price of waiting and of risk.

Who this hits

Lumentum holders took on Marvell price risk the moment the ratio was fixed, with no collar protecting them; the release describes no price floor. Marvell holders are the other side: they are issuing about a third of the company to buy a business whose shares had more than doubled in 2026, per CNBC, just as the AI trade has been selling off. Our chart shows Marvell about 41% below its June peak, and Lumentum is about 33% below its October 6 peak on the same data.

For the optical-networking supply chain, the logic Murphy gave is that AI clusters are moving from copper toward optical links, and that chip and laser design need to happen together. Rivals and customers will read this as a signal that independent optical suppliers are getting scarcer. That is an inference about how the industry may respond, not something either company said.

What to watch

• The merger 8-K and proxy filings on SEC EDGAR, which will show any termination fees and the conditions that could end the deal.
• Whether the 9% gap narrows. A shrinking gap would mean the market is growing more confident in the deal or in Marvell's stock.
• Marvell's preliminary fiscal third-quarter revenue, which the release says is in line with guidance at the midpoint, with the range narrowed to plus or minus 2% from plus or minus 5%.

Sources: Marvell and Lumentum joint press release of November 2, 2026; CNBC; Nasdaq.com quote pages (delayed, read 9:51 AM ET November 2); SEC EDGAR. Calculations marked as ours are derived from those figures. This is market information, not investment advice.